HER 2 POSITIVE BREAST CANCER
Clinical trials for HER 2 POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER 2 POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER 2 POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to delay advanced breast cancer growth
Disease control OngoingThis study is testing if adding a drug called palbociclib to the standard treatment helps people with a specific type of advanced breast cancer live longer without their cancer getting worse. It involves 518 adults whose cancer has spread, is HER2-positive, and is also fueled by …
Matched conditions: HER 2 POSITIVE BREAST CANCER
Phase: PHASE3 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New hope for metastatic breast cancer patients who've run out of options
Disease control OngoingThis study is testing whether combining two targeted drugs—sacituzumab govitecan and trastuzumab—can help control metastatic HER2-positive breast cancer that has progressed after standard treatments. The trial will enroll about 28 patients who have already received specific prior…
Matched conditions: HER 2 POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Adrienne G. Waks • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC